Android app on Google Play

PharmAthene (PIP) Slammed on SparVax rPA Clinial Hold News

August 10, 2012 9:04 AM EDT Send to a Friend
Get Alerts PIP Hot Sheet
Trade PIP Now!
Join SI Premium – FREE
PharmAthene (AMEX: PIP) shares are getting hit early Friday following news its SparVax rPA was place on clinical hold by the FDA.

Shares are down over 20 percent in early trading.




You May Also Be Interested In


Related Categories

FDA, Momentum Movers, Trader Talk

Add Your Comment